Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Name: Medpace Holdings Inc: Is Infosys Ltd. worth buying?
Item: Medpace Holdings Inc
Rating: 1.948305625
Author: Trendlyne DVM scores

Expensive Performer

about

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

520.57 2.03 (0.39%)

108.19% Gain from 52W Low

84,789.9

XNAS Volume

XNAS 16 Apr, 2026 10:58 AM (EDT)

Board Meeting

The next board meeting for Medpace Holdings Inc is on 23 Apr 2026 for the purpose of Medpace Holdings Inc First Quarter Earnings Conference Call for 2026 See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

25.7 / 100

Technically Neutral

52.4 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

500

1Yr Price target downside is -4%

12 analysts

Medpace Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

108.19% Gain from 52W Low

SWOT Analysis

Medpace Holdings Inc Live Price Chart